Clinical Research

HOME > R&D Achievement > Clinical Research > Article
 
DATE : 16-03-14 13:13
A Case of Recurrent In-Stent Restenosis with Abundant Proteoglycan Component.
 WRITER : stent
HIT : 4,538  
   C34._Korean_Circulation_J_2003;33_9_827-831..pdf (2.2M) [0] DATE : 2016-03-14 13:13:31
C34. Yang B, Jeong MH, Park OY, Kim JH, Park WS, Kim W, Ahn Y, Cho JG, Park JC, Kang JC; A Case of Recurrent In-Stent Restenosis with Abundant Proteoglycan Component. Korean Circulation J 2003;33(9)827-831.

(Abstract)
A percutaneous coronary intervention (PCI) is known to be one of effective methods in the treatment of coronary artery disease. However, restenosis remains a major limitation to a PCI. Although neointimal cell proliferation is suspected to be the major cause of coronary stent restenosis, few histological characterizations of recurrent instent restenosis exist. We report a case of a 61-year-old man suffering from unstable angina due to secondary coronary in-stent restenosis in the proximal left anterior descending artery (LAD). An atherectomized tissue, obtained by a directional coronary atherectomy, showed myxoid tissue, characterized by a few stellate smooth muscle cells in the abundant extracellular matrix, which was blue-colored proteoglycan on modified Movat staining.